91 related articles for article (PubMed ID: 21036716)
1. Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines.
Bundscherer A; Vogt T; Köhl G; Landthaler M; Hafner C
Anticancer Res; 2010 Oct; 30(10):4017-23. PubMed ID: 21036716
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines.
Bundscherer A; Hafner C; Maisch T; Becker B; Landthaler M; Vogt T
Oncol Rep; 2008 Feb; 19(2):547-53. PubMed ID: 18202806
[TBL] [Abstract][Full Text] [Related]
3. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits cellular growth, decreases Ki-67 expression and modifies apoptosis in ovarian cancer cell lines.
Vital-Reyes V; Rodríguez-Burford C; Chhieng DC; Oelschlager DK; Reyes-Fuentes A; Barnes M; Grizzle WE
Arch Med Res; 2006 Aug; 37(6):689-95. PubMed ID: 16824926
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K
Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
11. The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells.
Cerovac V; Monteserin-Garcia J; Rubinfeld H; Buchfelder M; Losa M; Florio T; Paez-Pereda M; Stalla GK; Theodoropoulou M
Cancer Res; 2010 Jan; 70(2):666-74. PubMed ID: 20068168
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of cyclooxygenase-2 selective inhibitor Celecoxib on human nephroblastoma].
Hu XL; Zhao LS; Liu W; Shu JB; Xu L; Wang ZF
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):340-1. PubMed ID: 22883675
[No Abstract] [Full Text] [Related]
14. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
15. [Celecoxib enhances the lethal effects of bleomycin in human tongue squamous carcinoma cell line Tca8113].
Li WZ; Wang XY; Li ZG; Zhang JH; Ding YQ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Mar; 44(3):140-3. PubMed ID: 19576016
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
Zhao S; Cai J; Bian H; Gui L; Zhao F
Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877
[TBL] [Abstract][Full Text] [Related]
17. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on the proliferation of hepatocellular carcinoma cells].
Tang BD; Zhou Q; Lin QH; Liu SC
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1511-3. PubMed ID: 17959527
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines.
Aissat N; Le Tourneau C; Ghoul A; Serova M; Bieche I; Lokiec F; Raymond E; Faivre S
Cancer Chemother Pharmacol; 2008 Jul; 62(2):305-13. PubMed ID: 17912526
[TBL] [Abstract][Full Text] [Related]
20. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
